Y3D-13646-04130
1 vaccination
1 coded response
2 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 372 / TN
- Registered
- 2021-06-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-05
Dose 1 — Pfizer-BioNTech
-
2021-06-19
Registered in v-safe
-
2021-06-21
Survey response — day 14, dose 1MedDRA: Dyspnoea, Paranasal sinus discomfort — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Shortness of breath and extreme sinus pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-21
Report sent to call center — day 14, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-06-24
- 2021-06-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-21 | Unsuccessful |
Free text
Release 9 — day 14, dose 1
Symptoms: Shortness of breath and extreme sinus pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release